Feature
June 22, 2018
Several studies designed to investigate immunotherapies and immunotherapeutic combinations for treatment of prostate cancer have yielded encouraging results.
…
June 22, 2018
A phase 2 trial of ruxolitinib met its primary endpoint of overall response rate for the treatment of patients with steroid-refractory graft-versus-host disease…
June 22, 2018
A trial assessing NBTXR3 plus radiotherapy met its primary endpoint of improved pathologic complete response rate compared with standard of care among patients with soft…
In the Journals
June 22, 2018
There were parallels between voting for Donald J. Trump in the 2016 presidential election and chronic opioid use, according to findings recently published in JAMA…